{"id":45308,"date":"2024-01-23T06:40:07","date_gmt":"2024-01-23T06:40:07","guid":{"rendered":"https:\/?p=45308"},"modified":"2024-01-23T06:40:07","modified_gmt":"2024-01-23T06:40:07","slug":"top-20-penny-stocks-in-2024","status":"publish","type":"post","link":"https:\/\/www.stocktargetadvisor.com\/blog\/top-20-penny-stocks-in-2024\/","title":{"rendered":"Top 20 Penny Stocks for Investors in 2024"},"content":{"rendered":"<p><span style=\"font-weight: 400;\">The recent rise in confidence in the stock market has been shattered by the fact that investors are now closely watching how higher interest rates and persistently high inflation will affect the market. But in this uncertain environment, some smart investors see market drops not as signs to stay away, but as great chances to buy or rebalance their portfolios carefully.<\/span><\/p>\n<p><span style=\"font-weight: 400;\"> This article highlights 20 promising penny stocks in an attempt to assist these types of investors. Picks were made based on recent purchases, financial performance, and potential in 2024&#8217;s tough economic situation.<\/span><\/p>\n<p>&nbsp;<\/p>\n<h2><strong>What are Penny Stocks?<\/strong><\/h2>\n<p><span style=\"font-weight: 400;\">Before we discuss the main topic, &#8220;How to buy the best 20 Penny Stock in 2024&#8221;. It is important to first understand what penny stocks are. Penny stocks are stocks with a low market price, often trading at a few cents or a few dollars per share. They are typically issued by small companies with limited market capitalization and are traded over the counter or on smaller exchanges. Due to their low prices, penny stocks are often seen as speculative investments that can deliver significant gains or incur substantial losses.<\/span><\/p>\n<p>&nbsp;<\/p>\n<h2><strong>Top Penny Stocks for 2024:<\/strong><span style=\"font-weight: 400;\">\u00a0\u00a0<\/span><\/h2>\n<p><span style=\"font-weight: 400;\">Followings are the top 20 Penny Stocks according to the Stock Target Advisor.<\/span><span style=\"font-weight: 400;\">\u00a0\u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400;\">\u00a0<\/span><\/p>\n<h3><span style=\"font-weight: 400;\"><strong>1. Aadi Bioscience Inc:<\/strong> (<\/span><strong><a href=\"https:\/\/www.stocktargetadvisor.com\/stock\/USA\/NSD\/AADI\">AADI: NSD<\/a><\/strong><span style=\"font-weight: 400;\">)<\/span><span style=\"font-weight: 400;\">\u00a0<\/span><\/h3>\n<p><span style=\"font-weight: 400;\">A pioneering biopharmaceutical company with innovative cancer therapies on the horizon. Investors interested in the healthcare sector should keep an eye on them.<\/span><\/p>\n<p><!-- STA Widget BEGIN --><\/p>\n<div>\n<div class=\"sta-analyst-rating-widget-display\">\n<p><a style=\"text-decoration: none; color: #4b6db5 !important;\" href=\"https:\/\/www.stocktargetadvisor.com\/stock\/USA\/NSD\/AADI\" target=\"_blank\" rel=\"noopener\">AADI Ratings<\/a> by Stock Target Advisor<\/p>\n<\/div>\n<p><script class=\"analyst-rating\" type=\"text\/javascript\" src=\"https:\/\/www.stocktargetadvisor.com\/assets\/js\/analyst_rating_widget.js\" data-symbol=\"AADI\" data-theme=\"wt_bg_trans\" data-uid=\"84077477865ae7ece4227665ae7ece42277\" data-width=\"700\" >\n\t\t<\/script><\/p>\n<\/div>\n<h3><span style=\"font-weight: 400;\"><strong>2. Allied Gold Corporation:<\/strong> (<\/span><strong><a href=\"https:\/\/www.stocktargetadvisor.com\/stock\/Canada\/TSX\/AAUC\">AAUC:CA<\/a><\/strong><span style=\"font-weight: 400;\">)<\/span><\/h3>\n<p><span style=\"font-weight: 400;\">Despite the volatile precious metals market, this mining company has strong mining operations and growth potential. It&#8217;s an attractive option for investors looking into the mining industry.<\/span><\/p>\n<p><!-- STA Widget BEGIN --><\/p>\n<div>\n<div class=\"sta-analyst-rating-widget-display\">\n<p><a style=\"text-decoration: none; color: #4b6db5 !important;\" href=\"https:\/\/www.stocktargetadvisor.com\/stock\/Canada\/TSX\/AAUC\" target=\"_blank\" rel=\"noopener\">AAUC: CA Ratings<\/a> by Stock Target Advisor<\/p>\n<\/div>\n<p><script class=\"analyst-rating\" type=\"text\/javascript\" src=\"https:\/\/www.stocktargetadvisor.com\/assets\/js\/analyst_rating_widget.js\" data-symbol=\"AAUC:CA\" data-theme=\"wt_bg_trans\" data-uid=\"85771945965ae7f038530065ae7f0385301\" data-width=\"700\" >\n\t\t<\/script><\/p>\n<\/div>\n<h3><span style=\"font-weight: 400;\"><strong>3. Abcourt Mines Inc:<\/strong> (<\/span><strong><a href=\"https:\/\/www.stocktargetadvisor.com\/stock\/Canada\/TSV\/ABI\">ABI: CA<\/a><\/strong><span style=\"font-weight: 400;\">)<\/span><\/h3>\n<p><span style=\"font-weight: 400;\">An established mining company making steady progress in the natural resources sector. They explore and expand in precious and base metals, making them an interesting investment opportunity.<\/span><\/p>\n<p><!-- STA Widget BEGIN --><\/p>\n<div>\n<div class=\"sta-analyst-rating-widget-display\">\n<p><a style=\"text-decoration: none; color: #4b6db5 !important;\" href=\"https:\/\/www.stocktargetadvisor.com\/stock\/Canada\/TSX\/AAUC\" target=\"_blank\" rel=\"noopener\">AAUC: CA Ratings<\/a> by Stock Target Advisor<\/p>\n<\/div>\n<p><script class=\"analyst-rating\" type=\"text\/javascript\" src=\"https:\/\/www.stocktargetadvisor.com\/assets\/js\/analyst_rating_widget.js\" data-symbol=\"AAUC:CA\" data-theme=\"wt_bg_trans\" data-uid=\"85771945965ae7f038530065ae7f0385301\" data-width=\"700\" >\n\t\t<\/script><\/p>\n<\/div>\n<h3><span style=\"font-weight: 400;\"><strong>4. Acumen Pharmaceuticals Inc:<\/strong> (<\/span><strong><a href=\"https:\/\/www.stocktargetadvisor.com\/stock\/USA\/NSD\/ABOS\">ABOS: NSD<\/a><\/strong><span style=\"font-weight: 400;\">)<\/span><\/h3>\n<p><span style=\"font-weight: 400;\">A rising star in the biotechnology industry, Acumen focuses on AI and healthcare technologies. With the market evolving rapidly, health tech-savvy investors should consider them.<\/span><\/p>\n<p><!-- STA Widget BEGIN --><\/p>\n<div>\n<div class=\"sta-analyst-rating-widget-display\">\n<p><a style=\"text-decoration: none; color: #4b6db5 !important;\" href=\"https:\/\/www.stocktargetadvisor.com\/stock\/Canada\/TSX\/AAUC\" target=\"_blank\" rel=\"noopener\">AAUC: CA Ratings<\/a> by Stock Target Advisor<\/p>\n<\/div>\n<p><script class=\"analyst-rating\" type=\"text\/javascript\" src=\"https:\/\/www.stocktargetadvisor.com\/assets\/js\/analyst_rating_widget.js\" data-symbol=\"AAUC:CA\" data-theme=\"wt_bg_trans\" data-uid=\"85771945965ae7f038530065ae7f0385301\" data-width=\"700\" >\n\t\t<\/script><\/p>\n<\/div>\n<h3><span style=\"font-weight: 400;\"><strong>5. Absci Corp:<\/strong> (<\/span><strong><a href=\"https:\/\/www.stocktargetadvisor.com\/stock\/USA\/NSD\/ABSI\">ABSI: NSD<\/a><\/strong><span style=\"font-weight: 400;\">)<\/span><b>\u00a0 <\/b><span style=\"font-weight: 400;\">\u00a0<\/span><\/h3>\n<p><span style=\"font-weight: 400;\">Cutting-edge research and developments in drug discovery and development make Absci Corp a potential catalyst for significant pharmaceutical advancements.<\/span><\/p>\n<p><!-- STA Widget BEGIN --><\/p>\n<div>\n<div class=\"sta-analyst-rating-widget-display\">\n<p><a style=\"text-decoration: none; color: #4b6db5 !important;\" href=\"https:\/\/www.stocktargetadvisor.com\/stock\/USA\/NSD\/ABSI\" target=\"_blank\" rel=\"noopener\">ABSI Ratings<\/a> by Stock Target Advisor<\/p>\n<\/div>\n<p><script class=\"analyst-rating\" type=\"text\/javascript\" src=\"https:\/\/www.stocktargetadvisor.com\/assets\/js\/analyst_rating_widget.js\" data-symbol=\"ABSI\" data-theme=\"wt_bg_trans\" data-uid=\"20799979765ae7f9e0a34c65ae7f9e0a34d\" data-width=\"700\" >\n\t\t<\/script><\/p>\n<\/div>\n<h3><span style=\"font-weight: 400;\"><strong>6. Arbutus Biopharma Corp:<\/strong> (<\/span><strong><a href=\"https:\/\/www.stocktargetadvisor.com\/stock\/USA\/NSD\/ABUS\">ABUS: NSD<\/a><\/strong><span style=\"font-weight: 400;\">)<\/span><span style=\"font-weight: 400;\">\u00a0<\/span><\/h3>\n<p><span style=\"font-weight: 400;\">Arbutus Biopharma is an excellent prospect if you are interested in biopharmaceuticals. They specialize in innovative treatments for chronic hepatitis B.<\/span><\/p>\n<p><!-- STA Widget BEGIN --><\/p>\n<div>\n<div class=\"sta-analyst-rating-widget-display\">\n<p><a style=\"text-decoration: none; color: #4b6db5 !important;\" href=\"https:\/\/www.stocktargetadvisor.com\/stock\/USA\/NSD\/ABUS\" target=\"_blank\" rel=\"noopener\">ABUS Ratings<\/a> by Stock Target Advisor<\/p>\n<\/div>\n<p><script class=\"analyst-rating\" type=\"text\/javascript\" src=\"https:\/\/www.stocktargetadvisor.com\/assets\/js\/analyst_rating_widget.js\" data-symbol=\"ABUS\" data-theme=\"wt_bg_trans\" data-uid=\"49242177365ae7fc613d0565ae7fc613d06\" data-width=\"700\" >\n\t\t<\/script><\/p>\n<\/div>\n<h3><span style=\"font-weight: 400;\"><strong>7. Aurora Cannabis Inc:<\/strong> (<\/span><strong><a href=\"https:\/\/www.stocktargetadvisor.com\/stock\/Canada\/TSX\/ACB\">ACB: CA<\/a><\/strong><span style=\"font-weight: 400;\">)\u00a0<\/span><\/h3>\n<p><span style=\"font-weight: 400;\">A leader in the cannabis industry, Aurora Cannabis is well-positioned as the acceptance and legalization of cannabis grows globally. Investors eyeing the cannabis market should take note.<\/span><\/p>\n<p><!-- STA Widget BEGIN --><\/p>\n<div>\n<div class=\"sta-analyst-rating-widget-display\">\n<p><a style=\"text-decoration: none; color: #4b6db5 !important;\" href=\"https:\/\/www.stocktargetadvisor.com\/stock\/USA\/NSD\/ABUS\" target=\"_blank\" rel=\"noopener\">ABUS Ratings<\/a> by Stock Target Advisor<\/p>\n<\/div>\n<p><script class=\"analyst-rating\" type=\"text\/javascript\" src=\"https:\/\/www.stocktargetadvisor.com\/assets\/js\/analyst_rating_widget.js\" data-symbol=\"ABUS\" data-theme=\"wt_bg_trans\" data-uid=\"49242177365ae7fc613d0565ae7fc613d06\" data-width=\"700\" >\n\t\t<\/script><\/p>\n<\/div>\n<h3><span style=\"font-weight: 400;\"><strong>8. Adicet Bio Inc:<\/strong> (<\/span><strong><a href=\"https:\/\/www.stocktargetadvisor.com\/stock\/USA\/NSD\/ACET\">ACET: NSD<\/a><\/strong><span style=\"font-weight: 400;\">)<\/span><\/h3>\n<p><span style=\"font-weight: 400;\">Adicet&#8217;s focus on cell therapies for cancer puts them at the forefront of oncological advancements. Health sector investors looking into cancer treatments should explore this option.<\/span><\/p>\n<p><!-- STA Widget BEGIN --><\/p>\n<div>\n<div class=\"sta-analyst-rating-widget-display\">\n<p><a style=\"text-decoration: none; color: #4b6db5 !important;\" href=\"https:\/\/www.stocktargetadvisor.com\/stock\/USA\/NSD\/ACET\" target=\"_blank\" rel=\"noopener\">ACET Ratings<\/a> by Stock Target Advisor<\/p>\n<\/div>\n<p><script class=\"analyst-rating\" type=\"text\/javascript\" src=\"https:\/\/www.stocktargetadvisor.com\/assets\/js\/analyst_rating_widget.js\" data-symbol=\"ACET\" data-theme=\"wt_bg_trans\" data-uid=\"45803660865ae7ffe4fcae65ae7ffe4fcaf\" data-width=\"700\" >\n\t\t<\/script><\/p>\n<\/div>\n<h3><span style=\"font-weight: 400;\"><strong>9. Lumen Technologies Inc:<\/strong> (<\/span><strong><a href=\"https:\/\/www.stocktargetadvisor.com\/stock\/USA\/NYE\/LUMN\">LUMN: NYE<\/a><\/strong><span style=\"font-weight: 400;\">)<\/span><span style=\"font-weight: 400;\">\u00a0<\/span><\/h3>\n<p><span style=\"font-weight: 400;\">Telecommunications enthusiasts should consider Lumen Technologies, known for their strategic investments in cloud and network services.<\/span><\/p>\n<p><!-- STA Widget BEGIN --><\/p>\n<div>\n<div class=\"sta-analyst-rating-widget-display\">\n<p><a style=\"text-decoration: none; color: #4b6db5 !important;\" href=\"https:\/\/www.stocktargetadvisor.com\/stock\/USA\/NYE\/LUMN\" target=\"_blank\" rel=\"noopener\">LUMN Ratings<\/a> by Stock Target Advisor<\/p>\n<\/div>\n<p><script class=\"analyst-rating\" type=\"text\/javascript\" src=\"https:\/\/www.stocktargetadvisor.com\/assets\/js\/analyst_rating_widget.js\" data-symbol=\"LUMN\" data-theme=\"wt_bg_trans\" data-uid=\"11189980365ae801a3887365ae801a38874\" data-width=\"700\" >\n\t\t<\/script><\/p>\n<\/div>\n<h3><span style=\"font-weight: 400;\"><strong>10. Taboola:<\/strong> (<\/span><strong><a href=\"https:\/\/www.stocktargetadvisor.com\/stock\/USA\/NSD\/TBLA\">TBLA: NSD<\/a><\/strong><span style=\"font-weight: 400;\">)<\/span><span style=\"font-weight: 400;\">\u00a0<\/span><\/h3>\n<p><span style=\"font-weight: 400;\">A player in the digital advertising landscape, Taboola Limited&#8217;s innovative approach to content discovery sets them apart in the online advertising world.<\/span><\/p>\n<p><!-- STA Widget BEGIN --><\/p>\n<div>\n<div class=\"sta-analyst-rating-widget-display\">\n<p><a style=\"text-decoration: none; color: #4b6db5 !important;\" href=\"https:\/\/www.stocktargetadvisor.com\/stock\/USA\/NSD\/TBLA\" target=\"_blank\" rel=\"noopener\">TBLA Ratings<\/a> by Stock Target Advisor<\/p>\n<\/div>\n<p><script class=\"analyst-rating\" type=\"text\/javascript\" src=\"https:\/\/www.stocktargetadvisor.com\/assets\/js\/analyst_rating_widget.js\" data-symbol=\"TBLA\" data-theme=\"wt_bg_trans\" data-uid=\"194570107665ae803d549e365ae803d549e4\" data-width=\"700\" >\n\t\t<\/script><\/p>\n<\/div>\n<p><!-- STA Widget END --><\/p>\n<h3><span style=\"font-weight: 400;\"><strong>11. Adaptive Biotechnologies Corporation:<\/strong> (<\/span><a href=\"https:\/\/www.stocktargetadvisor.com\/stock\/Europe\/F\/1HM\"><span style=\"font-weight: 400;\"><strong>1HM: F<\/strong><\/span><\/a><span style=\"font-weight: 400;\">)<\/span><\/h3>\n<p><span style=\"font-weight: 400;\">Personalized healthcare is gaining ground, and Adaptive Biotechnologies Corporation specializes in immune-driven medicine. They offer groundbreaking potential for the healthcare industry.<\/span><\/p>\n<p><!-- STA Widget BEGIN --><\/p>\n<div>\n<div class=\"sta-analyst-rating-widget-display\">\n<p><a style=\"text-decoration: none; color: #4b6db5 !important;\" href=\"https:\/\/www.stocktargetadvisor.com\/stock\/Europe\/F\/1HM\" target=\"_blank\" rel=\"noopener\">1HM: F Ratings<\/a> by Stock Target Advisor<\/p>\n<\/div>\n<p><script class=\"analyst-rating\" type=\"text\/javascript\" src=\"https:\/\/www.stocktargetadvisor.com\/assets\/js\/analyst_rating_widget.js\" data-symbol=\"1HM:F\" data-theme=\"wt_bg_trans\" data-uid=\"37395478365ae805b06d4e65ae805b06d4f\" data-width=\"700\" >\n\t\t<\/script><\/p>\n<\/div>\n<h3><span style=\"font-weight: 400;\"><strong>12. Grab Holdings Limited:<\/strong> (<\/span><strong><a href=\"https:\/\/www.stocktargetadvisor.com\/stock\/USA\/NSD\/GRABW\">GRABW: NSD<\/a><\/strong><span style=\"font-weight: 400;\">)<\/span><\/h3>\n<p><span style=\"font-weight: 400;\">Grab Holdings Limited is a Southeast Asian titan with a diverse portfolio in transportation, food delivery, and digital payments. Investors interested in the region should pay attention.<\/span><\/p>\n<p><!-- STA Widget BEGIN --><\/p>\n<div>\n<div class=\"sta-analyst-rating-widget-display\">\n<p><a style=\"text-decoration: none; color: #4b6db5 !important;\" href=\"https:\/\/www.stocktargetadvisor.com\/stock\/USA\/NSD\/GRABW\" target=\"_blank\" rel=\"noopener\">GRABW Ratings<\/a> by Stock Target Advisor<\/p>\n<\/div>\n<p><script class=\"analyst-rating\" type=\"text\/javascript\" src=\"https:\/\/www.stocktargetadvisor.com\/assets\/js\/analyst_rating_widget.js\" data-symbol=\"GRABW\" data-theme=\"wt_bg_trans\" data-uid=\"144290396465ae807d06d4a65ae807d06d4b\" data-width=\"700\" >\n\t\t<\/script><\/p>\n<\/div>\n<h3><span style=\"font-weight: 400;\"><strong>13. Opendoor Technologies Inc:<\/strong> (<\/span><strong><a href=\"https:\/\/www.stocktargetadvisor.com\/stock\/USA\/NSD\/OPEN\">OPEN: NSD<\/a><\/strong><span style=\"font-weight: 400;\">)<\/span><span style=\"font-weight: 400;\">\u00a0<\/span><\/h3>\n<p><span style=\"font-weight: 400;\">Opendoor Technologies Inc. is a game-changer in the real estate industry with its online platform for buying and selling homes. Real estate investors should explore this innovative option.<\/span><\/p>\n<p><!-- STA Widget BEGIN --><\/p>\n<div>\n<div class=\"sta-analyst-rating-widget-display\">\n<p><a style=\"text-decoration: none; color: #4b6db5 !important;\" href=\"https:\/\/www.stocktargetadvisor.com\/stock\/USA\/NSD\/GRABW\" target=\"_blank\" rel=\"noopener\">GRABW Ratings<\/a> by Stock Target Advisor<\/p>\n<\/div>\n<p><script class=\"analyst-rating\" type=\"text\/javascript\" src=\"https:\/\/www.stocktargetadvisor.com\/assets\/js\/analyst_rating_widget.js\" data-symbol=\"GRABW\" data-theme=\"wt_bg_trans\" data-uid=\"144290396465ae807d06d4a65ae807d06d4b\" data-width=\"700\" >\n\t\t<\/script><\/p>\n<\/div>\n<h3><span style=\"font-weight: 400;\"><strong>14. AbCellera Biologics Inc:<\/strong> (<\/span><strong><a href=\"https:\/\/www.stocktargetadvisor.com\/stock\/USA\/NSD\/ABCL\">ABCL: NSD<\/a><\/strong><span style=\"font-weight: 400;\">)<\/span><\/h3>\n<p><span style=\"font-weight: 400;\">Collaboration is key in fighting diseases, and AbCellera Biologics Inc. leads the way with its approach to antibody discovery and development.<\/span><\/p>\n<p><!-- STA Widget BEGIN --><\/p>\n<div>\n<div class=\"sta-analyst-rating-widget-display\">\n<p><a style=\"text-decoration: none; color: #4b6db5 !important;\" href=\"https:\/\/www.stocktargetadvisor.com\/stock\/USA\/NSD\/ABCL\" target=\"_blank\" rel=\"noopener\">ABCL Ratings<\/a> by Stock Target Advisor<\/p>\n<\/div>\n<p><script class=\"analyst-rating\" type=\"text\/javascript\" src=\"https:\/\/www.stocktargetadvisor.com\/assets\/js\/analyst_rating_widget.js\" data-symbol=\"ABCL\" data-theme=\"wt_bg_trans\" data-uid=\"99730020365ae80b9d2bb565ae80b9d2bb6\" data-width=\"700\" >\n\t\t<\/script><\/p>\n<\/div>\n<h3><span style=\"font-weight: 400;\"><strong>15. Qurate Retail Inc:<\/strong> (<\/span><strong><a href=\"https:\/\/www.stocktargetadvisor.com\/stock\/USA\/NSD\/QRTEA\">QRTEA: NSD<\/a><\/strong><span style=\"font-weight: 400;\">)<\/span><\/h3>\n<p><span style=\"font-weight: 400;\">Qurate Retail Inc. is known for its innovation in multi-platform commerce. Their digital retail strategies keep them ahead in a competitive market.<\/span><\/p>\n<p><!-- STA Widget BEGIN --><\/p>\n<div>\n<div class=\"sta-analyst-rating-widget-display\">\n<p><a style=\"text-decoration: none; color: #4b6db5 !important;\" href=\"https:\/\/www.stocktargetadvisor.com\/stock\/USA\/NSD\/QRTEA\" target=\"_blank\" rel=\"noopener\">QRTEA Ratings<\/a> by Stock Target Advisor<\/p>\n<\/div>\n<p><script class=\"analyst-rating\" type=\"text\/javascript\" src=\"https:\/\/www.stocktargetadvisor.com\/assets\/js\/analyst_rating_widget.js\" data-symbol=\"QRTEA\" data-theme=\"wt_bg_trans\" data-uid=\"132026511565ae80db692b065ae80db692b1\" data-width=\"700\" >\n\t\t<\/script><\/p>\n<\/div>\n<h3><span style=\"font-weight: 400;\"><strong>16. Nerdy Inc:<\/strong> (<\/span><a href=\"https:\/\/www.stocktargetadvisor.com\/stock\/USA\/NYE\/NRDY\"><span style=\"font-weight: 400;\"><strong>NRDY: NYE<\/strong><\/span><\/a><span style=\"font-weight: 400;\">)<\/span><span style=\"font-weight: 400;\">\u00a0<\/span><\/h3>\n<p><span style=\"font-weight: 400;\">With the rise of digital education, Nerdy, Inc. positions itself as a player in online learning and tutoring. Investors interested in the education sector should consider this option.<\/span><\/p>\n<p><!-- STA Widget BEGIN --><\/p>\n<div>\n<div class=\"sta-analyst-rating-widget-display\">\n<p><a style=\"text-decoration: none; color: #4b6db5 !important;\" href=\"https:\/\/www.stocktargetadvisor.com\/stock\/USA\/NYE\/NRDY\" target=\"_blank\" rel=\"noopener\">NRDY Ratings<\/a> by Stock Target Advisor<\/p>\n<\/div>\n<p><script class=\"analyst-rating\" type=\"text\/javascript\" src=\"https:\/\/www.stocktargetadvisor.com\/assets\/js\/analyst_rating_widget.js\" data-symbol=\"NRDY\" data-theme=\"wt_bg_trans\" data-uid=\"36662821865ae80fe6f39c65ae80fe6f39d\" data-width=\"700\" >\n\t\t<\/script><\/p>\n<\/div>\n<h3><span style=\"font-weight: 400;\"><strong>17. Compass Inc:<\/strong> (<\/span><strong><a href=\"https:\/\/www.stocktargetadvisor.com\/stock\/USA\/NYE\/COMP\">COMP: NYE<\/a><\/strong><span style=\"font-weight: 400;\">)<\/span><\/h3>\n<p><span style=\"font-weight: 400;\">Combining technology with traditional real estate practices, Compass Inc. offers a unique investment choice. Their real estate technology solutions set them apart.<\/span><\/p>\n<p><!-- STA Widget BEGIN --><\/p>\n<div>\n<div class=\"sta-analyst-rating-widget-display\">\n<p><a style=\"text-decoration: none; color: #4b6db5 !important;\" href=\"https:\/\/www.stocktargetadvisor.com\/stock\/USA\/NYE\/COMP\" target=\"_blank\" rel=\"noopener\">COMP Ratings<\/a> by Stock Target Advisor<\/p>\n<\/div>\n<p><script class=\"analyst-rating\" type=\"text\/javascript\" src=\"https:\/\/www.stocktargetadvisor.com\/assets\/js\/analyst_rating_widget.js\" data-symbol=\"COMP\" data-theme=\"wt_bg_trans\" data-uid=\"168259872465ae8121d5dc765ae8121d5dc8\" data-width=\"700\" >\n\t\t<\/script><\/p>\n<\/div>\n<h3><span style=\"font-weight: 400;\"><strong>18. Altice USA Inc:<\/strong> (<\/span><a href=\"https:\/\/www.stocktargetadvisor.com\/stock\/USA\/NYE\/ATUS\"><span style=\"font-weight: 400;\"><strong>ATUS: NYE<\/strong><\/span><\/a><span style=\"font-weight: 400;\">)<\/span><\/h3>\n<p><span style=\"font-weight: 400;\">A prominent player in the telecommunications industry, Altice USA, Inc. emphasizes broadband services and content. In a tech-driven world, they present a strong investment opportunity.<\/span><\/p>\n<p><!-- STA Widget BEGIN --><\/p>\n<div>\n<div class=\"sta-analyst-rating-widget-display\">\n<p><a style=\"text-decoration: none; color: #4b6db5 !important;\" href=\"https:\/\/www.stocktargetadvisor.com\/stock\/USA\/NYE\/COMP\" target=\"_blank\" rel=\"noopener\">COMP Ratings<\/a> by Stock Target Advisor<\/p>\n<\/div>\n<p><script class=\"analyst-rating\" type=\"text\/javascript\" src=\"https:\/\/www.stocktargetadvisor.com\/assets\/js\/analyst_rating_widget.js\" data-symbol=\"COMP\" data-theme=\"wt_bg_trans\" data-uid=\"168259872465ae8121d5dc765ae8121d5dc8\" data-width=\"700\" >\n\t\t<\/script><\/p>\n<\/div>\n<h3><span style=\"font-weight: 400;\"><strong>19. Nuvation Bio Inc:<\/strong> (<strong><a href=\"https:\/\/www.stocktargetadvisor.com\/stock\/USA\/NYE\/NUVB\">NUVB: NYE<\/a><\/strong>)<\/span><\/h3>\n<p><span style=\"font-weight: 400;\">Nuvation Bio Inc. focuses on oncology research and development, showcasing promising advancements in cancer treatment. Investors interested in the healthcare industry should keep them in mind.<\/span><\/p>\n<p><!-- STA Widget BEGIN --><\/p>\n<div>\n<div class=\"sta-analyst-rating-widget-display\">\n<p><a style=\"text-decoration: none; color: #4b6db5 !important;\" href=\"https:\/\/www.stocktargetadvisor.com\/stock\/USA\/NYE\/NUVB\" target=\"_blank\" rel=\"noopener\">NUVB Ratings<\/a> by Stock Target Advisor<\/p>\n<\/div>\n<p><script class=\"analyst-rating\" type=\"text\/javascript\" src=\"https:\/\/www.stocktargetadvisor.com\/assets\/js\/analyst_rating_widget.js\" data-symbol=\"NUVB\" data-theme=\"wt_bg_trans\" data-uid=\"134794174665ae8164ea59e65ae8164ea59f\" data-width=\"700\" >\n\t\t<\/script><\/p>\n<\/div>\n<h3><span style=\"font-weight: 400;\"><strong>20. Savara Inc:<\/strong> (<\/span><strong><a href=\"https:\/\/www.stocktargetadvisor.com\/stock\/USA\/NSD\/SVRA\">SVRA: NSD<\/a><\/strong><span style=\"font-weight: 400;\">)<\/span><\/h3>\n<p><span style=\"font-weight: 400;\">Specializing in rare respiratory diseases, Savara&#8217;s unique position in the pharmaceutical industry has caught the attention of investors. Their commitment to innovation and recent positive trial results could signal a bright future.<\/span><\/p>\n<p><!-- STA Widget BEGIN --><\/p>\n<div>\n<div class=\"sta-analyst-rating-widget-display\">\n<p><a style=\"text-decoration: none; color: #4b6db5 !important;\" href=\"https:\/\/www.stocktargetadvisor.com\/stock\/USA\/NSD\/SVRA\" target=\"_blank\" rel=\"noopener\">SVRA Ratings<\/a> by Stock Target Advisor<\/p>\n<\/div>\n<p><script class=\"analyst-rating\" type=\"text\/javascript\" src=\"https:\/\/www.stocktargetadvisor.com\/assets\/js\/analyst_rating_widget.js\" data-symbol=\"SVRA\" data-theme=\"wt_bg_trans\" data-uid=\"78622205165ae818e362b765ae818e362b8\" data-width=\"700\" >\n\t\t<\/script><\/p>\n<\/div>\n<h2><strong>Are penny stocks a good investment for investors?<\/strong><\/h2>\n<p><span style=\"font-weight: 400;\">Penny stocks are an attractive option for traders and investors looking for potential high returns with small investments. However, it&#8217;s important to be cautious and avoid scams and fraudulent schemes that target unsuspecting victims.\u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Blindly investing in penny stocks carries significant risks. However, with the right knowledge and thorough research, investing in penny stocks can offer rewarding opportunities. This guide provides a detailed overview of what penny stocks are and everything you need to know before getting started.<\/span><\/p>\n<p>&nbsp;<\/p>\n<h2>Conclusion:<\/h2>\n<p><span style=\"font-weight: 400;\">Although investing in penny stocks can come with high unpredictability, there are 20 options that have been carefully selected based on potential opportunities in various industries. It&#8217;s crucial to conduct thorough research and consult with a financial advisor to make informed decisions and mitigate risks when considering investing in penny stocks<\/span><\/p>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>The recent rise in confidence in the stock market has been shattered by the fact that investors are now closely watching how higher interest rates&#8230;<\/p>\n","protected":false},"author":17,"featured_media":45345,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-45308","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-blog"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v19.4 (Yoast SEO v21.4) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Top 20 Penny Stocks for Investors in 2024<\/title>\n<meta name=\"description\" content=\"Discover the top 20 promising penny stocks for 2024, including biopharmaceutical companies, mining operations, healthcare tech, and more.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.stocktargetadvisor.com\/blog\/top-20-penny-stocks-in-2024\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Top 20 Penny Stocks for Investors in 2024\" \/>\n<meta property=\"og:description\" content=\"Discover the top 20 promising penny stocks for 2024, including biopharmaceutical companies, mining operations, healthcare tech, and more.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.stocktargetadvisor.com\/blog\/top-20-penny-stocks-in-2024\/\" \/>\n<meta property=\"og:site_name\" content=\"Stock Target Advisor\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/StockTargetAdvisor\/\" \/>\n<meta property=\"article:published_time\" content=\"2024-01-23T06:40:07+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.stocktargetadvisor.com\/blog\/wp-content\/uploads\/2024\/01\/Top-20-Penny-Stocks-for-Investors-in-2024.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"628\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Muzzammil Ahmad\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@https:\/\/x.com\/Muzzammil625\" \/>\n<meta name=\"twitter:site\" content=\"@AdvisorTarget\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Muzzammil Ahmad\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/top-20-penny-stocks-in-2024\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/top-20-penny-stocks-in-2024\/\"},\"author\":{\"name\":\"Muzzammil Ahmad\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/81d743c6903933055039390e1e98b5f8\"},\"headline\":\"Top 20 Penny Stocks for Investors in 2024\",\"datePublished\":\"2024-01-23T06:40:07+00:00\",\"dateModified\":\"2024-01-23T06:40:07+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/top-20-penny-stocks-in-2024\/\"},\"wordCount\":1050,\"commentCount\":67,\"publisher\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#organization\"},\"articleSection\":[\"Market News &amp; Insights\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/www.stocktargetadvisor.com\/blog\/top-20-penny-stocks-in-2024\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/top-20-penny-stocks-in-2024\/\",\"url\":\"https:\/\/www.stocktargetadvisor.com\/blog\/top-20-penny-stocks-in-2024\/\",\"name\":\"Top 20 Penny Stocks for Investors in 2024\",\"isPartOf\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#website\"},\"datePublished\":\"2024-01-23T06:40:07+00:00\",\"dateModified\":\"2024-01-23T06:40:07+00:00\",\"description\":\"Discover the top 20 promising penny stocks for 2024, including biopharmaceutical companies, mining operations, healthcare tech, and more.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/top-20-penny-stocks-in-2024\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.stocktargetadvisor.com\/blog\/top-20-penny-stocks-in-2024\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/top-20-penny-stocks-in-2024\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.stocktargetadvisor.com\/blog\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Top 20 Penny Stocks for Investors in 2024\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#website\",\"url\":\"https:\/\/www.stocktargetadvisor.com\/blog\/\",\"name\":\"Stock Target Advisor\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.stocktargetadvisor.com\/blog\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#organization\",\"name\":\"Stock Target Advisor\",\"alternateName\":\"STA\",\"url\":\"https:\/\/www.stocktargetadvisor.com\/blog\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/logo\/image\/\",\"url\":\"http:\/\/stocktargetadvisor.com\/wp-content\/uploads\/2019\/10\/STAlogo.jpeg\",\"contentUrl\":\"http:\/\/stocktargetadvisor.com\/wp-content\/uploads\/2019\/10\/STAlogo.jpeg\",\"width\":\"225\",\"height\":\"225\",\"caption\":\"Stock Target Advisor\"},\"image\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/StockTargetAdvisor\/\",\"https:\/\/twitter.com\/AdvisorTarget\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/81d743c6903933055039390e1e98b5f8\",\"name\":\"Muzzammil Ahmad\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/d361e040abeba4e5b47d2fb7acae1401555042a5fc6862b11d7d01ac1722fed5?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/d361e040abeba4e5b47d2fb7acae1401555042a5fc6862b11d7d01ac1722fed5?s=96&d=mm&r=g\",\"caption\":\"Muzzammil Ahmad\"},\"description\":\"Muzzammil is a content writer at Stock Target Advisor. He has been writing stock news and analysis at Stock Target Advisor since 2023 and has worked in the financial domain in various roles since 2020. He has previously worked on an equity research firm that analyzed companies listed on the stock markets in the U.S. and Canada and performed fundamental and qualitative analyses of management strength, business strategy, and product\/services forecast as indicated by major brokers covering the stock.\",\"sameAs\":[\"https:\/\/www.linkedin.com\/in\/muzzammil-ahmad-a157b1190\/\",\"https:\/\/twitter.com\/https:\/\/x.com\/Muzzammil625\"],\"url\":\"https:\/\/www.stocktargetadvisor.com\/blog\/author\/muzzammil\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Top 20 Penny Stocks for Investors in 2024","description":"Discover the top 20 promising penny stocks for 2024, including biopharmaceutical companies, mining operations, healthcare tech, and more.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.stocktargetadvisor.com\/blog\/top-20-penny-stocks-in-2024\/","og_locale":"en_US","og_type":"article","og_title":"Top 20 Penny Stocks for Investors in 2024","og_description":"Discover the top 20 promising penny stocks for 2024, including biopharmaceutical companies, mining operations, healthcare tech, and more.","og_url":"https:\/\/www.stocktargetadvisor.com\/blog\/top-20-penny-stocks-in-2024\/","og_site_name":"Stock Target Advisor","article_publisher":"https:\/\/www.facebook.com\/StockTargetAdvisor\/","article_published_time":"2024-01-23T06:40:07+00:00","og_image":[{"width":1200,"height":628,"url":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-content\/uploads\/2024\/01\/Top-20-Penny-Stocks-for-Investors-in-2024.jpg","type":"image\/jpeg"}],"author":"Muzzammil Ahmad","twitter_card":"summary_large_image","twitter_creator":"@https:\/\/x.com\/Muzzammil625","twitter_site":"@AdvisorTarget","twitter_misc":{"Written by":"Muzzammil Ahmad","Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/top-20-penny-stocks-in-2024\/#article","isPartOf":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/top-20-penny-stocks-in-2024\/"},"author":{"name":"Muzzammil Ahmad","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/81d743c6903933055039390e1e98b5f8"},"headline":"Top 20 Penny Stocks for Investors in 2024","datePublished":"2024-01-23T06:40:07+00:00","dateModified":"2024-01-23T06:40:07+00:00","mainEntityOfPage":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/top-20-penny-stocks-in-2024\/"},"wordCount":1050,"commentCount":67,"publisher":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#organization"},"articleSection":["Market News &amp; Insights"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.stocktargetadvisor.com\/blog\/top-20-penny-stocks-in-2024\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/top-20-penny-stocks-in-2024\/","url":"https:\/\/www.stocktargetadvisor.com\/blog\/top-20-penny-stocks-in-2024\/","name":"Top 20 Penny Stocks for Investors in 2024","isPartOf":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#website"},"datePublished":"2024-01-23T06:40:07+00:00","dateModified":"2024-01-23T06:40:07+00:00","description":"Discover the top 20 promising penny stocks for 2024, including biopharmaceutical companies, mining operations, healthcare tech, and more.","breadcrumb":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/top-20-penny-stocks-in-2024\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.stocktargetadvisor.com\/blog\/top-20-penny-stocks-in-2024\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/top-20-penny-stocks-in-2024\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.stocktargetadvisor.com\/blog\/"},{"@type":"ListItem","position":2,"name":"Top 20 Penny Stocks for Investors in 2024"}]},{"@type":"WebSite","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#website","url":"https:\/\/www.stocktargetadvisor.com\/blog\/","name":"Stock Target Advisor","description":"","publisher":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.stocktargetadvisor.com\/blog\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#organization","name":"Stock Target Advisor","alternateName":"STA","url":"https:\/\/www.stocktargetadvisor.com\/blog\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/logo\/image\/","url":"http:\/\/stocktargetadvisor.com\/wp-content\/uploads\/2019\/10\/STAlogo.jpeg","contentUrl":"http:\/\/stocktargetadvisor.com\/wp-content\/uploads\/2019\/10\/STAlogo.jpeg","width":"225","height":"225","caption":"Stock Target Advisor"},"image":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/StockTargetAdvisor\/","https:\/\/twitter.com\/AdvisorTarget"]},{"@type":"Person","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/81d743c6903933055039390e1e98b5f8","name":"Muzzammil Ahmad","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/d361e040abeba4e5b47d2fb7acae1401555042a5fc6862b11d7d01ac1722fed5?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/d361e040abeba4e5b47d2fb7acae1401555042a5fc6862b11d7d01ac1722fed5?s=96&d=mm&r=g","caption":"Muzzammil Ahmad"},"description":"Muzzammil is a content writer at Stock Target Advisor. He has been writing stock news and analysis at Stock Target Advisor since 2023 and has worked in the financial domain in various roles since 2020. He has previously worked on an equity research firm that analyzed companies listed on the stock markets in the U.S. and Canada and performed fundamental and qualitative analyses of management strength, business strategy, and product\/services forecast as indicated by major brokers covering the stock.","sameAs":["https:\/\/www.linkedin.com\/in\/muzzammil-ahmad-a157b1190\/","https:\/\/twitter.com\/https:\/\/x.com\/Muzzammil625"],"url":"https:\/\/www.stocktargetadvisor.com\/blog\/author\/muzzammil\/"}]}},"_links":{"self":[{"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/posts\/45308","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/users\/17"}],"replies":[{"embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/comments?post=45308"}],"version-history":[{"count":3,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/posts\/45308\/revisions"}],"predecessor-version":[{"id":45313,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/posts\/45308\/revisions\/45313"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/media\/45345"}],"wp:attachment":[{"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/media?parent=45308"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/categories?post=45308"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/tags?post=45308"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}